Showing results 3 to 11 of 11
< previous
| Issue Date | Title | Author(s) |
| 2023-05-17 | Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia. | Moles, E; Howard, CB; Huda, P; Karsa, M; McCalmont, H; Kimpton, K; Duly, A; Chen, Y; Huang, Y; Tursky, ML; Ma, D; Bustamante, S; Pickford, R; Connerty, P; Omari, S; Jolly, CJ; Joshi, S; Shen, S; Pimanda, JE; Dolnikov, A; Cheung, LC; Kotecha, RS; Norris, MD; Haber, M; de Bock, CE; Somers, K; Lock, RB; Thurecht, KJ; Kavallaris, M |
| 2018-12-10 | Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic Leukemia | Jing, D; Huang, Y; Liu, X; Sia, KCS; Zhang, JC; Tai, X; Wang, M; Toscan, CE; McCalmont, H; Evans, K; Mayoh, C; Poulos, RC; Span, M; Mi, J; Zhang, C; Wong, JWH; Beck, D; Pimanda, JE; Lock, RB |
| 2016-07-01 | MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation | Huang, Y; Thoms, JAI; Tursky, ML; Knezevic, K; Beck, D; Chandrakanthan, V; Suryani, S; Olivier, J; Boulton, A; Glaros, EN; Thomas, SR; Lock, RB; MacKenzie, KL; Bushweller, JH; Wong, JWH; Pimanda, JE |
| 2019-12-09 | A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia | Krivtsov, AV; Evans, K; Gadrey, JY; Eschle, BK; Hatton, C; Uckelmann, HJ; Ross, KN; Perner, F; Olsen, SN; Pritchard, T; McDermott, L; Jones, CD; Jing, D; Braytee, A; Chacon, D; Earley, E; McKeever, BM; Claremon, D; Gifford, AJ; Lee, HJ; Teicher, BA; Pimanda, JE; Beck, D; Perry, JA; Smith, MA; McGeehan, GM; Lock, RB; Armstrong, SA |
| 2021-07-06 | Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia | Van Thillo, Q; De Bie, J; Seneviratne, JA; Demeyer, S; Omari, S; Balachandran, A; Zhai, V; Tam, WL; Sweron, B; Geerdens, E; Gielen, O; Provost, S; Segers, H; Boeckx, N; Marshall, GM; Cheung, BB; Isobe, K; Kato, I; Takita, J; Amos, TG; Deveson, IW; McCalmont, H; Lock, RB; Oxley, EP; Garwood, MM; Dickins, RA; Uyttebroeck, A; Carter, DR; Cools, J; de Bock, CE |
| 2015-04-15 | Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias | Tursky, ML; Beck, D; Thoms, JAI; Huang, Y; Kumari, A; Unnikrishnan, A; Knezevic, K; Evans, K; Richards, LA; Lee, E; Morris, J; Goldberg, L; Izraeli, S; Wong, JWH; Olivier, J; Lock, RB; MacKenzie, KL; Pimanda, JE |
| 2022-01 | PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia. | Li, J; Hlavka-Zhang, J; Shrimp, JH; Piper, C; Dupéré-Richér, D; Roth, JS; Jing, D; Casellas Román, HL; Troche, C; Swaroop, A; Kulis, M; Oyer, JA; Will, CM; Shen, M; Riva, A; Bennett, RL; Ferrando, AA; Hall, MD; Lock, RB; Licht, JD |
| 2020-06 | Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression. | Toscan, CE; Jing, D; Mayoh, C; Lock, RB |
| 2023-12-01 | Small zinc doped iron oxide tracers for magnetic particle imaging | Kim Duong, HT; Abdibastami, A; Gloag, L; Bongers, A; Shanehsazzadeh, S; Nelson, M; Cousins, A; Bayat, N; McCalmont, H; Lock, RB; Sulway, S; Biazick, J; Justin Gooding, J; Tilley, RD |
